Efforts to lower insulin costs could stiff-arm future diabetes treatments more effective and less painful than insulin needle jabs, Johns Hopkins senior resident Michael Rose, MD, wrote for The Atlantic.
Read the full post on Becker's Hospital Review - Healthcare News
